FundedIQ
Biotechnology

Alzprotect: Funding, Investors & Team (Sep 2026)

AlzProtect is a biopharmaceutical organization creating drug competitors from disclosure to clinical preliminaries for the treatment of neurodegenerative illnesses including Alzheimer's sickness (AD) and vagrant tauopathies like Progressive Supranuclear Palsy (PSP).

www.alzprotect.com Street, United States 1-10 employees
Biotechnology Clinical Trials Medical Pharmaceutical
Total raised
$340k
Rounds
1
Latest
Grant
Jun 2022

Alzprotect has raised $340k across 1 funding round on record, the most recent a Grant of $340k announced in Jun 2022.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Alzprotect Company Profile and Key Stats

Total funding raised
$340k
across 1 round on record
Funding rounds on record
1
Latest funding round
Grant
$340k in Jun 2022
Employees
1-10
reported band
Headquarters
Street, United States

Latest funding round on record: Jun 2022.

Alzprotect Funding Rounds

Date
Round
Amount
Grant
$340k

Alzprotect Founders and Leadership Team

Name
Role
Contact
Patricia Melnyk
Founder

No contact details are on record for this team yet.

Alzprotect Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M
1,065

Alzprotect's latest round of $340k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Alzprotect in Biotechnology and Street

Companies Similar to Alzprotect

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Alzprotect Funding FAQs

What does Alzprotect do?

AlzProtect is a biopharmaceutical organization creating drug competitors from disclosure to clinical preliminaries for the treatment of neurodegenerative illnesses including Alzheimer's sickness (AD) and vagrant tauopathies like Progressive Supranuclear Palsy (PSP).

How much funding has Alzprotect raised?

Alzprotect has raised $340k across 1 round on record. The most recent is a Grant of $340k announced in Jun 2022.

When did Alzprotect last raise funding?

Alzprotect's most recent funding round on record is a Grant of $340k, announced in Jun 2022.

Who founded Alzprotect?

FundedIQ lists Patricia Melnyk (Founder) at Alzprotect.

Where is Alzprotect headquartered?

Alzprotect is based in Street, Maryland, United States.

How many employees does Alzprotect have?

Alzprotect is in the 1-10 employee band.

How does Alzprotect's funding compare to other Biotechnology startups?

Alzprotect's latest round of $340k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Alzprotect Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Alzprotect is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.